[{"uuid": "99ef5d99-7bda-3e9a-bd83-b9baf5630730", "title": "Genelux Names Matthew Pulisic as CFO", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/genelux-names-matthew-pulisic-cfo-153928305.html", "providerPublishTime": 1738597168, "type": "STORY", "relatedTickers": ["GNLX"]}, {"uuid": "b078785b-f0d3-30ce-a9eb-8f8094c2120b", "title": "Guidewire Software to Join S&P MidCap 400, Arrowhead Pharmaceuticals to Move to S&P SmallCap 600", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guidewire-software-join-p-midcap-105056876.html", "providerPublishTime": 1737629456, "type": "STORY", "relatedTickers": ["GWRE", "ARWR", "APO-PA"]}, {"uuid": "eb58707d-07e0-345b-814e-d6b551a78a7c", "title": "Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/guidewire-software-set-join-p-225400503.html", "providerPublishTime": 1737586440, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/mLg0nL3t2KIE2ftLe7_cLg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f1899b0e5eec4d5b6b57ddd388b15567", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Ueog_P65geqkijI4EZXVnQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f1899b0e5eec4d5b6b57ddd388b15567", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["APO", "APO-PA", "ARWR", "GWRE", "B", "SPGI"]}, {"uuid": "36ac24cd-1ebf-31a9-8c7e-a42fb9bb03e9", "title": "Arrowhead Pharmaceuticals to Webcast Fiscal 2025 First Quarter Results", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/arrowhead-pharmaceuticals-webcast-fiscal-2025-210000179.html", "providerPublishTime": 1737579600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/WsOKLj6rjbW508ntrLKCzg--~B/aD0zMzU7dz0xNjA5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6beb4c674eb6710039c86a058fb34cff", "width": 1609, "height": 335, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/njgRRrj0NidsxZbSH7wvEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6beb4c674eb6710039c86a058fb34cff", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARWR"]}, {"uuid": "2243705d-6636-392a-a1ad-70d3951aaf9b", "title": "Sector Update: Tech Stocks Flat to Lower Premarket Thursday", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-tech-stocks-flat-lower-141258376.html", "providerPublishTime": 1737641578, "type": "STORY", "relatedTickers": ["GWRE"]}, {"uuid": "90e4ba6c-7276-3dea-8920-960db08cb0c4", "title": "Sector Update: Health Care Stocks Rise Premarket Tuesday", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-141151811.html", "providerPublishTime": 1737468711, "type": "STORY", "relatedTickers": ["ARWR", "NANO.PA"]}, {"uuid": "41f93d7a-3f4a-30e9-a1ba-099a0e51f3a5", "title": "Arrowhead Pharmaceuticals' New Drug Application for Plozasiran Accepted by FDA", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/arrowhead-pharmaceuticals-apos-drug-application-220202903.html", "providerPublishTime": 1737151322, "type": "STORY", "relatedTickers": ["ARWR"]}, {"uuid": "c2374673-a8f7-3d1d-813a-65f5797352d2", "title": "Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/arrowhead-pharmaceuticals-announces-acceptance-drug-213000505.html", "providerPublishTime": 1737149400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_zoPdhgPh2X0BNg8So5yHA--~B/aD0zMzU7dz0xNjA5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/284d0b85c388f22c000c8661de9da33d", "width": 1609, "height": 335, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/G6xaFm0Ld7ZJOVpcM9_CUQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/284d0b85c388f22c000c8661de9da33d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARWR"]}, {"uuid": "0fa336c2-7cf3-33ef-a2fa-0f144012ad29", "title": "SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/srpt-stock-rises-23-time-124000929.html", "providerPublishTime": 1736167200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IYksUEF.ZX5JOPFmQ194jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["SRPT"]}, {"uuid": "a5c7bf5d-c2c4-3fef-892c-f08d88b3a4f0", "title": "ARWR: License and Collaboration Deal with Sarepta Includes $825 Million Upon Closing\u2026", "publisher": "Zacks Small Cap Research", "link": "https://finance.yahoo.com/news/arwr-license-collaboration-deal-sarepta-112400539.html", "providerPublishTime": 1733225040, "type": "STORY", "relatedTickers": ["ARWR", "SRPT"]}, {"uuid": "78687bef-7072-3cac-99b9-2e6d1e4a199b", "title": "Arrowhead Pharmaceuticals Doses First Patients in Trial of Potential Obesity Drug", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/arrowhead-pharmaceuticals-doses-first-patients-133621914.html", "providerPublishTime": 1734960981, "type": "STORY", "relatedTickers": ["ARWR"]}, {"uuid": "1b2165fa-167e-3fcb-b1ca-053075d664e1", "title": "Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/arrowhead-pharmaceuticals-initiates-phase-1-123000809.html", "providerPublishTime": 1734957000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bupTMcV_Labfa3TycPEUhA--~B/aD0zMzU7dz0xNjA5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7bcd16c37c68fcddc25cb731d82b9a50", "width": 1609, "height": 335, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/BnJarrMB7Ua1FKDN42AA8A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7bcd16c37c68fcddc25cb731d82b9a50", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARWR"]}]